| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 146, 20-26, Copyright © 1995 by American Society for Investigative Pathology
REGULAR ARTICLES |
MP Bronner, C Culin, JC Reed and EE Furth
Department of Pathology, University of Washington Medical Center, Seattle.
We report overexpression of the proto-oncogene bcl-2 in gastrointestinal adenocarcinoma and its precursor lesions. The bcl-2 proto-oncogene is centrally involved in the oncogenesis of human follicular lymphoma via a chromosomal translocation t(14;18)(q32;q21) and is also expressed in the epithelial regenerative compartment or the basal crypts of the normal colon and small intestine. We describe an immunohistochemical analysis of fixed, paraffin-embedded tissue using both a polyclonal rabbit and a monoclonal mouse antibody to the Bcl-2 protein. In addition to confirming bcl-2 expression in normal colonic and small intestinal crypts, we also observed expression in the gastric epithelial regenerative compartment, the mucous neck region. No increased expression was found in nonneoplastic or inflammatory gastrointestinal conditions, including ulcerative colitis, Crohn's disease, or inflammatory or hamartomatous polyps. Increased bcl-2 expression, however, was present in hyperplastic colonic polyps and in the majority of dysplastic lesions, from the earliest precursors through large adenomas, high grade flat dysplasia, and adenocarcinoma, all in comparison with adjacent internal control normal epithelium. Increased expression was present in dysplastic glandular lesions from all gastrointestinal sites, including colon, small bowel, and stomach. Furthermore, bcl-2 expression was frequently abnormal in nondysplastic epithelium surrounding dysplastic lesions, suggesting that altered expression occurred before the development of morphological dysplasia. Specifically, directly contiguous morphologically nondysplastic epithelium often showed abnormal bcl-2 expression throughout the full length of the crypt-villus axis. This expression pattern gradually diminished to involve only the crypt base (the normal pattern of expression), proceeding away from malignant or dysplastic lesions. Abnormal bcl-2 immunoreactivity in 1), the earliest precursor dysplastic lesions and its persistence throughout neoplastic progression and 2), contiguous morphologically unaltered nondysplastic epithelium suggests that bcl-2 alterations occur early during the morphological and molecular sequence of events leading to gastrointestinal epithelial neoplasia.
This article has been cited by other articles:
![]() |
K. L. Campbell, A. McTiernan, S. S. Li, B. E. Sorensen, Y. Yasui, J. W. Lampe, I. B. King, C. M. Ulrich, R. E. Rudolph, M. L. Irwin, et al. Effect of a 12-Month Exercise Intervention on the Apoptotic Regulating Proteins Bax and Bcl-2 in Colon Crypts: A Randomized Controlled Trial Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1767 - 1774. [Abstract] [Full Text] [PDF] |
||||
![]() |
Abstracts Gut, April 1, 2006; 55(suppl_2): a1 - a119. [Full Text] [PDF] |
||||
![]() |
J. Lu, M. S. Caplan, A. P. Saraf, D. Li, L. Adler, X. Liu, and T. Jilling Platelet-activating factor-induced apoptosis is blocked by Bcl-2 in rat intestinal epithelial cells Am J Physiol Gastrointest Liver Physiol, February 1, 2004; 286(2): G340 - G350. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Kim, J. K. Park, K. Y. Lee, W. I. Yang, S. H. Yun, J. Sung, and J. S. Min p53, BCL-2, and Ki-67 Expression According to Tumor Response After Concurrent Chemoradiotherapy for Advanced Rectal Cancer Ann. Surg. Oncol., June 1, 2001; 8(5): 418 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Agoff, T. A. Brentnall, D. A. Crispin, S. L. Taylor, S. Raaka, R. C. Haggitt, M. W. Reed, I. A. Afonina, P. S. Rabinovitch, A. C. Stevens, et al. The Role of Cyclooxygenase 2 in Ulcerative Colitis-Associated Neoplasia Am. J. Pathol., September 1, 2000; 157(3): 737 - 745. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Jones, A. Islur, R. Haq, M. Mascarenhas, M. A. Karmali, M. H. Perdue, B. W. Zanke, and P. M. Sherman Escherichia coli Shiga toxins induce apoptosis in epithelial cells that is regulated by the Bcl-2 family Am J Physiol Gastrointest Liver Physiol, May 1, 2000; 278(5): G811 - G819. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Dong, W. Wang, F. Wang, M. Stoner, J. C. Reed, M. Harigai, I. Samudio, M. P. Kladde, C. Vyhlidal, and S. Safe Mechanisms of Transcriptional Activation of bcl-2 Gene Expression by 17beta -Estradiol in Breast Cancer Cells J. Biol. Chem., November 5, 1999; 274(45): 32099 - 32107. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sarbia, C. Loberg, M. Wolter, J. Arjumand, H. Heep, G. Reifenberger, and H. E. Gabbert Expression of Bcl-2 and Amplification of c-myc Are Frequent in Basaloid Squamous Cell Carcinomas of the Esophagus Am. J. Pathol., October 1, 1999; 155(4): 1027 - 1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Nardone, S Staibano, A Rocco, E Mezza, F P D'Armiento, L Insabato, A Coppola, G Salvatore, A Lucariello, N Figura, et al. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis Gut, June 1, 1999; 44(6): 789 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. McEntee, C.-H. Chiu, and J. Whelan Relationship of ß-catenin and Bcl-2 expression to sulindac-induced regression of intestinal tumors in Min mice Carcinogenesis, April 1, 1999; 20(4): 635 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Mostafa, S. A. Sheweita, and P. J. O'Connor Relationship between Schistosomiasis and Bladder Cancer Clin. Microbiol. Rev., January 1, 1999; 12(1): 97 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Jones and G. J. Gores Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas, and intestine Am J Physiol Gastrointest Liver Physiol, December 1, 1997; 273(6): G1174 - G1188. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Coopersmith, C. Chandrasekaran, M. S. McNevin, and J. I. Gordon Bi-transgenic Mice Reveal that K-rasVal12 Augments a p53-independent Apoptosis When Small Intestinal Villus Enterocytes Reenter the Cell Cycle J. Cell Biol., July 14, 1997; 138(1): 167 - 179. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |